RxDoctor Payments Data

Drew Johnson, MD

Family Medicine · Freeport, ILNPI 1821589821

Payments from drug & device makers

$1,376in general payments, 2019–2025

Across 88 payments — averaging $15.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceutical Holding Company Ltd.$187
  • Lilly USA, LLC$167
  • GSK$144
  • Novo Nordisk$102
  • Novartis$99
  • AbbVie$86
  • plus $589 from 14 others

What the payments were for

  • Food & beverage$1,376100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,376 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$59,951
Medicare patients
262
Services billed
632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$30,304
XareltoRivaroxaban22$20,478
OzempicSemaglutide11$17,947
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$13,007
JanuviaSitagliptin Phosphate14$12,691
FarxigaDapagliflozin Propanediol16$10,826
TrulicityDulaglutide11$10,682
MyrbetriqMirabegron13$5,401
Novolog FlexpenInsulin Aspart13$2,065
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,572
Nano 2nd Gen Pen NeedlePen Needle, Diabetic13$1,354
Bumetanide14$724
Rosuvastatin Calcium50$719
Atorvastatin Calcium93$626
Potassium Chloride43$625

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$57$30,30433 claims
Johnson & JohnsonXarelto$52$20,47822 claims
Novo NordiskOzempic$102$17,94711 claims
GSKTrelegy Ellipta$144$13,00720 claims
AstraZenecaFarxiga$32$10,82616 claims
Lilly USA, LLCTrulicity$167$10,68211 claims
Astellas Pharma US IncMyrbetriq$13$5,40113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Freeport

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →